Sara Renna (S Renna)

Publication Activity (10 Years)

Years Active: 2019-2020
Publications (10 Years): 5

Top Topics

Patients With Inflammatory Bowel Disease

Ulcerative Colitis

Emergency Department

Top Venues

Alimentary pharmacology & therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Giuseppe Maria Garbo, Sara Renna, Valentina Caputo, Elisabetta Orlando, Fabio Salvatore Macaluso, Rosalba Orlando, Maria Rita Bongiorno, Ambrogio Orlando
Letter: psoriasiform eruption during vedolizumab therapy. Alimentary pharmacology & therapeutics 50 (3) (2020)
Maria Concetta Miceli, Chiara Arcuri, Sara Renna, Ambrogio Orlando, Giuseppe Provenzano
Letter: golimumab efficacy in patients with Crohn's disease and concomitant severe arthritis. Alimentary pharmacology & therapeutics 51 (12) (2020)
Barbara Scrivo, Sara Renna, Angelo Casà, Noemi Monachino, Fabio Salvatore Macaluso, Ambrogio Orlando
Letter: mesalazine-a safe drug with rare serious adverse events. Alimentary pharmacology & therapeutics 51 (11) (2020)
Fabio Salvatore Macaluso, R Orlando, Sara Renna, C Sapienza, M Ventimiglia, G Rizzuto, M Cottone, A Orlando
Letter: the addition of an immunosuppressant in patients with unsatisfactory response to vedolizumab. Alimentary pharmacology & therapeutics 47 (7) (2019)
Fabio Salvatore Macaluso, Maria Cappello, Enrica Giuffrida, Walter Fries, Andrea Centritto, Antonio Carlo Privitera, Gaetano Inserra, Roberto Vassallo, Antonio Magnano, Elisa Vinci, Serena Garufi, Marco Ventimiglia, Sara Renna, Rosalba Orlando, Giulia Rizzuto, Mario Cottone, Ambrogio Orlando, null null
Letter: SPOSIB SB2-a Sicilian prospective observational study of IBD patients treated with infliximab biosimilar SB2. Alimentary pharmacology & therapeutics 49 (2) (2019)